CVRx, Inc. (NASDAQ:CVRX) Director Kirk G. Nielsen Purchases 10,976 Shares

CVRx, Inc. (NASDAQ:CVRXGet Rating) Director Kirk G. Nielsen bought 10,976 shares of the firm’s stock in a transaction on Thursday, May 19th. The shares were purchased at an average cost of $5.04 per share, with a total value of $55,319.04. Following the transaction, the director now directly owns 1,685,466 shares in the company, valued at approximately $8,494,748.64. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Shares of CVRX stock traded down $0.14 during trading hours on Monday, hitting $5.11. 57,613 shares of the company were exchanged, compared to its average volume of 124,012. The firm has a market cap of $104.76 million and a P/E ratio of -0.10. CVRx, Inc. has a fifty-two week low of $4.60 and a fifty-two week high of $29.00. The company has a 50 day simple moving average of $5.62 and a two-hundred day simple moving average of $8.90.

CVRx (NASDAQ:CVRXGet Rating) last issued its earnings results on Monday, April 25th. The company reported ($0.49) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.49). CVRx had a negative return on equity of 148.64% and a negative net margin of 311.83%. The company had revenue of $4.08 million for the quarter, compared to analysts’ expectations of $3.76 million. On average, analysts anticipate that CVRx, Inc. will post -2.14 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the stock. Citigroup Inc. lifted its holdings in shares of CVRx by 117.7% in the 4th quarter. Citigroup Inc. now owns 2,020 shares of the company’s stock worth $25,000 after purchasing an additional 1,092 shares in the last quarter. US Bancorp DE purchased a new stake in CVRx in the 3rd quarter worth about $32,000. New York State Common Retirement Fund purchased a new stake in CVRx in the 4th quarter worth about $39,000. Royal Bank of Canada purchased a new position in CVRx during the 3rd quarter valued at about $71,000. Finally, California State Teachers Retirement System purchased a new position in CVRx during the 3rd quarter valued at about $73,000. Institutional investors own 65.94% of the company’s stock.

CVRx Company Profile (Get Rating)

CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.

Featured Articles

Insider Buying and Selling by Quarter for CVRx (NASDAQ:CVRX)

Receive News & Ratings for CVRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVRx and related companies with MarketBeat.com's FREE daily email newsletter.